At a glance
Studies Addressing Rare Neurodegenerative Diseases including ALS is a federal competitive grant from Food and Drug Administration for the science & technology sector. Eligible applicants: State governments; County governments; Special district governments; Small businesses; Native American tribal organizations (other than Federally recognized tribal governments); Private institutions of higher education;. Applications are accepted on a rolling basis. Apply via the official listing at www.grants.gov.
- Amount
- See listing
- Deadline
- Rolling
- Type
- Competitive
- Status
- Forecasted
About this program
The purpose of this funding opportunity announcement (FOA) is to support studies that advance medical product development of interventions intended to prevent, diagnose, mitigate, treat, or cure ALS and other rare neurodegenerative diseases in adults and children. Through the support of these studies, FDA expects to address critical knowledge gaps, exert a significant impact on rare neurodegenerative diseases, and to inform current or future product development.
Who can apply
State governments; County governments; Special district governments; Small businesses; Native American tribal organizations (other than Federally recognized tribal governments); Private institutions of higher education; City or township governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Native American tribal governments (Federally recognized); Independent school districts; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; For profit organizations other than small businesses; Public and State controlled institutions of higher education; Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"; Public housing authorities/Indian housing authorities
How to apply
Apply through Grants.gov using funding opportunity number FOR-FD-25-006. Register your organization (SAM.gov + Grants.gov) before the deadline, then submit the application package listed in the official notice.
Apply at official sourceRelated grants
- Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional) NIH · Up to $6.3M · Nov 15, 2027 Open
- NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed) NIH · See listing · Jul 12, 2027 Open
- Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not Allowed) NIH · See listing · Sep 25, 2026 Open
- Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional) NIH · Up to $25K · Jun 2, 2027 Open